That's because they also have anti-cancer properties. This article looks at the new drugs for bone metastases, how they work, and other possible treatments. Strengthening bones affected by metastases, ...

Breast cancer progresses by invading healthy tissues and often begins by spreading within the breast itself before extending to nearby lymph nodes. If the cancer cells enter the lymphatic system, they ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The exciting findings that we're presenting in the poster ...

In a joint statement with is wife Meghan Ory, 42, Reardon, 49, disclosed he had undergone treatment for tonsil cancer ... a long road between these two pictures,' he shared, offering a contrast ...

Legendary Eagles linebacker Bill Bergey has died after a long battle with cancer, his son announced on social media. He was 79. Jake Bergey, a former pro lacrosse player, posted the news Wednesday ...

It felt suffocating at first. I was suddenly in a hospital bed, with metastatic cancer up and down my bones, across both lungs, in my brain. I desperately wanted to find other cancer patients who ...

Facing a cancer diagnosis is never ... Among all the cancers, lung, prostate, and breast are most likely to affect the vertebral column through metastases,” said Dr Rane. The spine is made ...

The authors have assembled comprehensive datasets from various subtypes of localized and lung-metastatic breast cancer cells, as well as from healthy and cancerous lung cells. They identified ...

In February 2024, the agent was granted fast track designation from the FDA as a monotherapy for the treatment of adult patients with ER+/HER2- locally advanced or metastatic breast cancer that ...

FDA approved Braftovi, Erbitux, and mFOLFOX6 for BRAF V600E mutation-positive metastatic colorectal cancer. BREAKWATER trial showed a 61% objective response rate for the treatment group versus 40% for ...

Addition of the CDK 4/6 inhibitor improved progression-free survival by 15.2 months for patients with HR-positive/HER2-positive advanced breast cancer.